From: High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer
 |  | ACAT2 expression |  |  | |
---|---|---|---|---|---|
 | Total (n = 77) | Low (n = 26) | High (n = 51) | χ2 value | P |
Mean age at diagnosis (years) | Â | Â | Â | 1.08 | 0.298 |
< 55 | 41 | 16 | 25 |  |  |
≥ 55 | 36 | 10 | 26 |  |  |
FIGO stage | Â | Â | Â | 7.01 | 0.030 |
I | 3 | 3 | 0 | Â | Â |
II | 2 | 0 | 2 | Â | Â |
III - IV | 72 | 23 | 49 | Â | Â |
Weight (kg) | Â | Â | Â | 0.06 | 0.812 |
< 55 | 40 | 14 | 26 |  |  |
≥ 55 | 37 | 12 | 25 |  |  |
Height (cm) | Â | Â | Â | 2.32 | 0.127 |
< 158 | 36 | 9 | 27 |  |  |
≥ 158 | 41 | 17 | 24 |  |  |
Pathological type | Â | Â | Â | 0.99 | 0.610 |
Serous carcinoma | 72 | 24 | 48 | 0.232 | 0.630 |
High-grade | 62 | 20 | 42 | Â | Â |
Low-grade | 10 | 4 | 6 | Â | Â |
Mix serous carcinoma | 4 | 2 | 2 | Â | Â |
Clear cell carcinoma | 1 | 0 | 1 | Â | Â |
Grades | Â | Â | Â | 0.20 | 0.655 |
High | 67 | 22 | 45 | Â | Â |
Low | 10 | 4 | 6 | Â | Â |
Tumor size(cm) |  |  |  | <0.01 | 0.949 |
< 8.5 | 47 | 16 | 31 |  |  |
≥ 8.5 | 30 | 10 | 20 |  |  |
Chemo-response | Â | Â | Â | 4.17 | 0.041 |
Sensitivity | 47 | 20 | 27 | Â | Â |
Resistance | 30 | 6 | 24 | Â | Â |
CA125 (U/ml) |  |  |  | <0.01 | 0.942 |
< 2475 | 59 | 19 | 40 |  |  |
≥ 2475 | 16 | 5 | 11 |  |  |
HE4(pmol/L) | Â | Â | Â | 2.56 | 0.278 |
< 733 | 40 | 11 | 29 |  |  |
≥ 733 | 29 | 13 | 16 |  |  |
Miss | 8 | 2 | 6 | Â | Â |
Ascites volume (ml) | Â | Â | Â | 2.84 | 0.092 |
< 1492 | 37 | 9 | 28 |  |  |
≥ 1492 | 40 | 17 | 23 |  |  |
Surgical satisfaction | Â | Â | Â | 3.98 | 0.136 |
R0 | 12 | 7 | 5 | Â | Â |
R1 | 50 | 14 | 36 | Â | Â |
R2 | 15 | 5 | 10 | Â | Â |